These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8581485)
1. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's beta-amyloid peptide in cultured vascular smooth muscle cells. Mazur-Kolecka B; Frackowiak J; Wiśniewski HM Brain Res; 1995 Nov; 698(1-2):217-22. PubMed ID: 8581485 [TBL] [Abstract][Full Text] [Related]
2. The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of beta-amyloid angiopathy (CAA). Mazur-Kolecka B; Kowal D; Sukontasup T; Dickson D; Frackowiak J Brain Res; 2003 Sep; 983(1-2):48-57. PubMed ID: 12914965 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Evans KC; Berger EP; Cho CG; Weisgraber KH; Lansbury PT Proc Natl Acad Sci U S A; 1995 Jan; 92(3):763-7. PubMed ID: 7846048 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342 [TBL] [Abstract][Full Text] [Related]
5. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. Jordán J; Galindo MF; Miller RJ; Reardon CA; Getz GS; LaDu MJ J Neurosci; 1998 Jan; 18(1):195-204. PubMed ID: 9412500 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro. McGeer PL; Walker DG; Pitas RE; Mahley RW; McGeer EG Brain Res; 1997 Feb; 749(1):135-8. PubMed ID: 9070638 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Prior R; Wihl G; Urmoneit B Ann N Y Acad Sci; 2000 Apr; 903():180-6. PubMed ID: 10818506 [TBL] [Abstract][Full Text] [Related]
8. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470 [TBL] [Abstract][Full Text] [Related]
9. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E alters metabolism of AbetaPP in cells engaged in beta-amyloidosis. Mazur-Kolecka B; Frackowiak J; Krzeslowska J; Ramakrishna N; Haske T; Emmerling MR; Zhang W; Kim KS; Wisniewski HM J Neuropathol Exp Neurol; 1999 Mar; 58(3):288-95. PubMed ID: 10197820 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Mahley RW; Nathan BP; Pitas RE Ann N Y Acad Sci; 1996 Jan; 777():139-45. PubMed ID: 8624076 [TBL] [Abstract][Full Text] [Related]
12. Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Zeleny M; Swertfeger DK; Weisgraber KH; Hui DY Biochemistry; 2002 Oct; 41(39):11820-3. PubMed ID: 12269825 [TBL] [Abstract][Full Text] [Related]
13. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease. Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683 [TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
15. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides. Ma J; Brewer HB; Potter H Neurobiol Aging; 1996; 17(5):773-80. PubMed ID: 8892351 [TBL] [Abstract][Full Text] [Related]
17. Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures. Puttfarcken PS; Manelli AM; Falduto MT; Getz GS; LaDu MJ J Neurochem; 1997 Feb; 68(2):760-9. PubMed ID: 9003067 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Nathan BP; Jiang Y; Wong GK; Shen F; Brewer GJ; Struble RG Brain Res; 2002 Feb; 928(1-2):96-105. PubMed ID: 11844476 [TBL] [Abstract][Full Text] [Related]
19. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease. Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Yang DS; Small DH; Seydel U; Smith JD; Hallmayer J; Gandy SE; Martins RN Neuroscience; 1999; 90(4):1217-26. PubMed ID: 10338292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]